May 2017 - groupH

Transforming trial design and positioning for novel oncology therapy

5th May 2017/in Oncology, TPP shaping and validation

Rare and Orphan Diseases, Gene and Cell Therapy

5th May 2017/in Uncategorised

Demand Assessment and Attribute Testing in Neuropathic Pain

5th May 2017/in CNS, Demand assessments

Multiple waves of in-depth market research to support the commercial forecast assumptions for a novel antibiotic used to treat Gram negative infections

5th May 2017/in Demand assessments, Infectious Disesases

Breast Cancer Strategic Gaming Workshop to understand fit of developmental product into future treatment landscape

5th May 2017/in Competitor workshops, Oncology

Disease Area Strategy and TPP Development Workshop to identify unmet needs in future Cancer treatment landscape and build options for clinical development

5th May 2017/in Disease area strategy, Oncology, TPP shaping and validation

Future Market Scenario Planning Workshop to inform commercial and clinical strategy for a developmental CNS product

5th May 2017/in CNS, Scenario planning workshops

Market Opportunity Map to inform development for a novel autoimmune product

5th May 2017/in Autoimmune, Market landscaping

Validating early TPPs in a Payer Focused ‘Willingness to Pay’ 360 degree Stakeholder Dermatology Project

5th May 2017/in Dermatology, TPP shaping and validation